DK154090C - Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose under anvendelse af det fremstillede monoklonale antistof - Google Patents

Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose under anvendelse af det fremstillede monoklonale antistof

Info

Publication number
DK154090C
DK154090C DK517180A DK517180A DK154090C DK 154090 C DK154090 C DK 154090C DK 517180 A DK517180 A DK 517180A DK 517180 A DK517180 A DK 517180A DK 154090 C DK154090 C DK 154090C
Authority
DK
Denmark
Prior art keywords
monoclonal antibody
procedure
cell line
diagnosis
procedures
Prior art date
Application number
DK517180A
Other languages
Danish (da)
English (en)
Other versions
DK517180A (da
DK154090B (da
Inventor
Patrick Chung-Shu Kung
Gideon Goldstein
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22277479&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK154090(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of DK517180A publication Critical patent/DK517180A/da
Publication of DK154090B publication Critical patent/DK154090B/da
Application granted granted Critical
Publication of DK154090C publication Critical patent/DK154090C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hybrid Cells (AREA)
DK517180A 1979-12-04 1980-12-03 Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose under anvendelse af det fremstillede monoklonale antistof DK154090C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9997079 1979-12-04
US06/099,970 US4364933A (en) 1979-12-04 1979-12-04 Monoclonal antibody to a human thymocyte antigen and methods of preparing same

Publications (3)

Publication Number Publication Date
DK517180A DK517180A (da) 1981-06-05
DK154090B DK154090B (da) 1988-10-10
DK154090C true DK154090C (da) 1989-03-06

Family

ID=22277479

Family Applications (1)

Application Number Title Priority Date Filing Date
DK517180A DK154090C (da) 1979-12-04 1980-12-03 Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose under anvendelse af det fremstillede monoklonale antistof

Country Status (22)

Country Link
US (1) US4364933A (sv)
EP (1) EP0030449B1 (sv)
JP (2) JPS5695120A (sv)
AT (1) ATE12660T1 (sv)
AU (1) AU545222B2 (sv)
CA (1) CA1181702A (sv)
DE (2) DE3070479D1 (sv)
DK (1) DK154090C (sv)
ES (1) ES8303096A1 (sv)
FI (1) FI75598C (sv)
GR (1) GR71724B (sv)
HK (1) HK24286A (sv)
IE (1) IE50672B1 (sv)
IL (1) IL61620A (sv)
MY (1) MY8600516A (sv)
NO (1) NO159886C (sv)
NZ (1) NZ195645A (sv)
PH (1) PH20122A (sv)
PT (1) PT72144B (sv)
SG (1) SG7086G (sv)
YU (1) YU43224B (sv)
ZA (1) ZA807564B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582797A (en) * 1980-09-25 1986-04-15 The Salk Institute For Biological Studies Monoclonal antibodies specific for human hematopoietic cell surface glycoproteins
DE3105150A1 (de) * 1981-02-12 1982-08-19 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg Herstellung von anti-t-lymphozyten-globulin.
US4434156A (en) 1981-10-26 1984-02-28 The Salk Institute For Biological Studies Monoclonal antibodies specific for the human transferrin receptor glycoprotein
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4474892A (en) * 1983-02-16 1984-10-02 Board Of Trustees Of The Leland Stanford Junior University Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4677056A (en) * 1983-08-18 1987-06-30 Sloan-Kettering Institute For Cancer Research Monoclonal antibody subsetting human helper and killer T-cells and method
JPS60231699A (ja) * 1983-11-09 1985-11-18 Aichiken 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
CN1068524C (zh) * 1997-06-23 2001-07-18 叶庆炜 一种治疗顽症牛皮癣的药物
WO1999026658A1 (en) 1997-11-24 1999-06-03 Wong Johnson T Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
US7653260B2 (en) 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system
CA3198072A1 (en) 2020-10-09 2022-04-14 Pfizer Inc. Cd1a antibodies and uses thereof

Also Published As

Publication number Publication date
FI75598B (fi) 1988-03-31
IL61620A0 (en) 1981-01-30
DE30449T1 (de) 1984-07-19
DK517180A (da) 1981-06-05
NO159886B (no) 1988-11-07
EP0030449B1 (en) 1985-04-10
ES8303096A1 (es) 1983-02-16
AU6496280A (en) 1981-06-11
PT72144A (en) 1981-01-01
EP0030449A2 (en) 1981-06-17
AU545222B2 (en) 1985-07-04
PT72144B (en) 1982-07-05
JPS5695120A (en) 1981-08-01
MY8600516A (en) 1986-12-31
GR71724B (sv) 1983-06-22
YU306680A (en) 1984-02-29
NO159886C (no) 1989-02-15
IL61620A (en) 1984-07-31
PH20122A (en) 1986-10-02
JPS649997B2 (sv) 1989-02-21
HK24286A (en) 1986-04-11
JPH0160230B2 (sv) 1989-12-21
SG7086G (en) 1986-08-01
FI803755L (fi) 1981-06-05
JPS6413991A (en) 1989-01-18
IE802508L (en) 1981-06-04
ATE12660T1 (de) 1985-04-15
DK154090B (da) 1988-10-10
YU43224B (en) 1989-06-30
NO803659L (no) 1981-06-05
ES497423A0 (es) 1982-12-16
NZ195645A (en) 1984-07-06
FI75598C (sv) 1988-07-11
EP0030449A3 (en) 1981-11-11
IE50672B1 (en) 1986-06-11
DE3070479D1 (en) 1985-05-15
ZA807564B (en) 1982-07-28
US4364933A (en) 1982-12-21
CA1181702A (en) 1985-01-29

Similar Documents

Publication Publication Date Title
DK153954C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose og diagnostisk praeparat med det fremstillede monoklonale antistof
DK154092C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose og diagnostisk praeparat med det fremstillede monoklonale antistof
DK154091C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof samt fremgangsmaade til diagnose hermed og diagnostisk praeparat indeholdende antistoffet
DK154087C (da) Monoklonalt antistof, fremstilling heraf, hybrodimacellelinie til anvendelse ved fremstilling heraf, fremgangsmaade til anvendelse heraf samt diagnostisk praeparat indeholdende antistoffet
DK154086C (da) Monoklonalt antistof, fremstilling deraf, hybridomacellelinie til anvendelse ved fremstilling heraf samt fremgangsmaade til diagnose ved anvendelse heraf
DK154090C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose under anvendelse af det fremstillede monoklonale antistof
DK154093C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt diagnostisk praeparat med det fremstillede monoklonale antistof
DK153891C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose og diagnostisk praeparat med det fremstillede monoklonale antistof